LA
GILD icon

Lifeworks Advisors’s Gilead Sciences GILD Stock Holding History

Lifeworks Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.3M Buy
74,262
+3,486
+5% +$488K 1.33% 13
2025
Q4 		$8.69M Sell
70,776
-8,695
-11% -$1.06M 1.12% 14
2025
Q3 		$8.82M Sell
79,471
-1,048
-1% -$119K 1.17% 17
2025
Q2 		$8.93M Buy
80,519
+53
+0.1% +$5.64K 1.33% 15
2025
Q1 		$9.02M Sell
80,466
-1,968
-2% -$203K 1.5% 12
2024
Q4 		$7.61M Buy
82,434
+5,315
+7% +$479K 1.37% 11
2024
Q3 		$6.47M Sell
77,119
-275
-0.4% -$21K 1.27% 17
2024
Q2 		$5.31M Buy
77,394
+6,991
+10% +$467K 1.48% 21
2024
Q1 		$5.16M Buy
70,403
+9,727
+16% +$748K 1.44% 16
2023
Q4 		$4.92M Buy
60,676
+4,111
+7% +$320K 1.7% 12
2023
Q3 		$4.24M Buy
56,565
+3,464
+7% +$266K 1.65% 13
2023
Q2 		$4.09M Buy
53,101
+11,343
+27% +$905K 1.74% 17
2023
Q1 		$3.46M Sell
41,758
-8,341
-17% -$691K 1.64% 13
2022
Q4 		$4.3M Buy
50,099
+881
+2% +$69.8K 2.42% 8
2022
Q3 		$3.86M Sell
49,218
-2,325
-5% -$147K 2.2% 10
2022
Q2 		$3.19M Buy
51,543
+46,437
+909% +$2.88M 2.02% 11
2022
Q1 		$304K Buy
+5,106
New +$326K 0.2% 97

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Lifeworks Advisors's GILD Position: Q1 2026 in Review

Lifeworks Advisors increased its Gilead Sciences (GILD) stake by 4.9% in Q1 2026, buying an estimated $488K and bringing the position to 74,262 shares worth $10.3M. The position accounts for 1.33% of the portfolio, ranked #13.

Lifeworks Advisors first reported a position in GILD in Q1 2022 and has held it in 17 quarters since. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Lifeworks Advisors held 74,262 shares of Gilead Sciences worth $10.3M as of Q1 2026.
  • Lifeworks Advisors bought 3,486 Gilead Sciences shares in Q1 2026, an estimated $488K.
  • Gilead Sciences made up 1.33% of Lifeworks Advisors's portfolio in Q1 2026, its #13 holding.
  • Lifeworks Advisors first reported a position in Gilead Sciences in Q1 2022 and has held it in 17 quarters since.
  • 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Lifeworks Advisors's 13F filing for Q1 2026, filed 4 May 2026.